Cancer startup raises $125M for Keytruda combo drug trial

Cancer startup raises $125M for Keytruda combo drug trial

bizjournals

Published

RA Capital and Boxer Capital continued a busy financing week Wednesday, investing undisclosed amounts in a local startup working with cancer giant Merck & Co.  iTeos Therapeutics wrapped up an oversubscribed $125 million extension of its Series B round this week that drew in RA Capital, Boxer Capital, as well as the Invus Group and MPM Capital. Both RA Capital and Boxer Capital also contributed to Pandion Therapeutics' Series B round that closed this week. The B2 round adds to roughly $16.5…

Full Article